Evidence map›Paper›PMID 27401578›Full record

ArticleAntimicrobial agents and chemotherapy2016

Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin.

Paris Laskaris, Ahmad Atrouni, José Antonio Calera, Christophe d'Enfert, Hélène Munier-Lehmann, Jean-Marc Cavaillon, Jean-Paul Latgé, Oumaïma Ibrahim-Granet

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Influence of Zinc onJournal of fungi (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. At the metal-metabolite interface inMicrobiology (Reading, England) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Aspergillus fumigatus and Aspergillosis in 2019.Clinical microbiology reviews · 2019
    Review
  12. Review
  13. Antimicrobial agents and chemotherapy · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Paris LaskarisInstitut Pasteur, Cytokines & Inflammation, Département Infection & Epidemiology, Paris, France.
Ahmad AtrouniInstitut Pasteur, Cytokines & Inflammation, Département Infection & Epidemiology, Paris, France.
José Antonio CaleraUniversidad de Salamanca, Instituto de Biologia Funcional y Genómica, Departamento de Microbiología y Genética, Salamanca, Spain.
Christophe d'EnfertInstitut Pasteur, Unité Biologie et Pathogénicité Fongiques, Département Mycologie, Paris, France INRA, USC2019, Paris, France.
Hélène Munier-LehmannInstitut Pasteur, Unité de Chimie et Biocatalyse, CNRS UMR3523, Paris, France.
Jean-Marc CavaillonInstitut Pasteur, Cytokines & Inflammation, Département Infection & Epidemiology, Paris, France.
Jean-Paul LatgéInstitut Pasteur, Unité des Aspergillus, Paris, France.
Oumaïma Ibrahim-GranetInstitut Pasteur, Cytokines & Inflammation, Département Infection & Epidemiology, Paris, France ogranet@pasteur.fr.
Institut Pasteur · FRUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus fumigatus can infect immunocompromised patients, leading to high mortality rates due to the lack of reliable treatment options. This pathogen requires uptake of zinc from host tissues in order to successfully grow and cause virulence. Reducing the availability of that micronutrient could help treat A. fumigatus infections. In this study, we examined the in vitro effects of seven chelators using a bioluminescent strain of A. fumigatus 1,10-Phenanthroline and N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN) proved to be the chelators most effective at inhibiting fungal growth. Intraperitoneal administration of either phenanthroline or TPEN resulted in a significant improvement in survival and decrease of weight loss and fungal burden for immunosuppressed mice intranasally infected with A. fumigatus In vitro both chelators had an indifferent effect when employed in combination with caspofungin. The use of TPEN in combination with caspofungin also significantly increased survival compared to that when using these drugs individually. Our results suggest that zinc chelation may be a valid strategy for dealing with A. fumigatus infections and that both phenanthroline and TPEN could potentially be used either independently or in combination with caspofungin, indicating that their use in combination with other antifungal treatments might also be applicable.

Indexed as

AnimalsAntifungal AgentsAspergillosisAspergillus fumigatusCaspofunginChelating AgentsClioquinolDrug Therapy, CombinationEchinocandinsEthylaminesImmune SeraImmunocompromised HostLipopeptidesMaleMice, Inbred BALB CPhenanthrolines1,10-phenanthrolineAntifungal AgentsCaspofunginChelating AgentsClioquinolEchinocandinsEthylaminesImmune SeraLipopeptidesN,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diaminePhenanthrolinesPyridinesZinc

Identifiers

PMID27401578
PMCPMC5038287
OpenAlexW2465883341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.